Outcome in heart failure with preserved ejection fraction: The role of myocardial structure and right ventricular performance

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Goliasch, Georg ^a   Zotter Tufaro, Caroline ^a   Aschauer, Stefan ^a   Duca, Franz ^a   Koell, Benedikt ^a   Kammerlander, Andreas A ^a   Ristl, Robin ^a   Lang, Irene M ^a   Maurer, Gerald ^a   Mascherbauer, Julia ^a   Bonderman, Diana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; ECHOCARDIOGRAPH; EXTRACELLULAR MATRIX; FEMALE; HEART DEATH; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE SIZE; HEMODYNAMIC MONITORING; HUMAN; HUMAN TISSUE; INTERVENTION STUDY; LEFT VENTRICULAR END DIASTOLIC DIAMETER; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK FACTOR; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIAC MUSCLE; HEART FAILURE; HEART VENTRICLE; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MYOCARDIUM; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 84941975803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134479     Document Type: Article

References (27)

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England journal of medicine. 2006;355:251-9. PMID: 16855265
2. Writing Group M, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667 PMID: 20019324
3. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology. 2013;62:263-71. doi: 10.1016/j.jacc.2013.02. 092 PMID: 23684677
4. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. Journal of the American College of Cardiology. 2009;53:1119-26. doi: 10.1016/j.jacc.2008.11.051 PMID: 19324256
5. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. European heart journal. 2014.
6. Mohammed SF, Hussain I, Abou Ezzeddine OF, Takahama H, Kwon SH, Forfia P, et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation. 2014;130:2310-20. doi: 10.1161/CIRCULATIONAHA.113.008461 PMID: 25391518
7. Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, et al. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circulation Cardiovascular imaging. 2013;6:1056-65. doi: 10.1161/CIRCIMAGING. 113.000633 PMID: 24036385
8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European journal of heart failure. 2012;14:803-69. doi: 10.1093/eurjhf/hfs105 PMID: 22828712
9. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62:e147-239. doi: 10.1016/j.jacc.2013.05.019 PMID: 23747642
10. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. European heart journal. 2007;28:2539-50. PMID: 17428822
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography.. 2005;18:1440-63.
12. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Journal of cardiovascular magnetic resonance: official journal of the Society for Cardiovascular Magnetic Resonance.. 2008;10:35.
13. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest. 2013;143:758-66. PMID: 23580984
14. Garvey W, Fathi A, Bigelow F, Carpenter B, Jimenez C. A combined elastic, fibrin and collagen stain. Stain technology. 1987;62:365-8. PMID: 2448920
15. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. Journal of the American College of Cardiology. 2001;37:183-8. PMID: 11153735
16. Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, et al. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circulation Heart failure. 2014;7:288-99. doi: 10.1161/CIRCHEARTFAILURE.113.000854 PMID: 24365774
17. Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation. 2015;131:550-9. doi: 10.1161/CIRCULATIONAHA.114.009625 PMID: 25552356
18. Zile MR, Baicu CF, Ikonomidis JS, Stroud RE, Nietert PJ, Bradshaw AD, et al. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation. 2015;131:1247-59. doi: 10.1161/CIRCULATIONAHA.114.013215 PMID: 25637629
19. Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circulation Heart failure. 2014;7:123-30. doi: 10.1161/CIRCHEARTFAILURE.113.000568 PMID: 24162898
20. McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, et al. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. Journal of the American Heart Association. 2013;2:e005694. doi: 10.1161/JAHA.112.005694 PMID: 23525446
21. Lund LH, Donal E, Oger E, Hage C, Persson H, Haugen-Lofman I, et al. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction. European journal of heart failure. 2014;16:992-1001. doi: 10.1002/ejhf.137 PMID: 25046483
22. Kapoor JR, Heidenreich PA. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. American heart journal. 2010;159:75-80. doi: 10.1016/j.ahj.2009. 10.026 PMID: 20102870
23. Funk GC, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest. 2008;133:1354-9. doi: 10.1378/chest.07-2685 PMID: 18339780
24. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. Journal of the American College of Cardiology. 2012;59:998-1005. doi: 10.1016/j.jacc.2011.11.040 PMID: 22402071
25. Andersen MJ, Hwang SJ, Kane GC, Melenovsky V, Olson TP, Fetterly K, et al. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Circulation Heart failure. 2015;8:542-50. doi: 10.1161/CIRCHEARTFAILURE.114.002114 PMID: 25857307
26. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. Journal of the American College of Cardiology. 2006;47:1997-2004. PMID: 16697316
27. Kass DA. Assessment of diastolic dysfunction. Invasive modalities. Cardiology clinics. 2000;18:571-86. PMID: 10986590